Publication identifier(s): 20457606
Bidirectional lipid inositolphosphotransferase (experimentally validated). Homologous to animal phosphatidylcholine:ceramide cholinephosphotransferases. Expanded on the Trypanosoma lineage.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 16 |
GO:0110165 | cellular anatomical entity | 1 | 16 |
GO:0005768 | endosome | 7 | 1 |
GO:0005794 | Golgi apparatus | 5 | 1 |
GO:0005886 | plasma membrane | 3 | 1 |
GO:0020016 | ciliary pocket | 2 | 1 |
GO:0031410 | cytoplasmic vesicle | 6 | 1 |
GO:0031982 | vesicle | 4 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0097708 | intracellular vesicle | 5 | 1 |
Related structures:
AlphaFold database: E9B725
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 16 |
GO:0006643 | membrane lipid metabolic process | 4 | 16 |
GO:0006665 | sphingolipid metabolic process | 4 | 16 |
GO:0006793 | phosphorus metabolic process | 3 | 16 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 16 |
GO:0006807 | nitrogen compound metabolic process | 2 | 16 |
GO:0008152 | metabolic process | 1 | 16 |
GO:0009987 | cellular process | 1 | 16 |
GO:0016310 | phosphorylation | 5 | 16 |
GO:0044237 | cellular metabolic process | 2 | 16 |
GO:0044238 | primary metabolic process | 2 | 16 |
GO:0044255 | cellular lipid metabolic process | 3 | 16 |
GO:0071704 | organic substance metabolic process | 2 | 16 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 16 |
GO:0006066 | alcohol metabolic process | 3 | 1 |
GO:0006576 | biogenic amine metabolic process | 5 | 1 |
GO:0006580 | ethanolamine metabolic process | 5 | 1 |
GO:0006672 | ceramide metabolic process | 4 | 1 |
GO:0008610 | lipid biosynthetic process | 4 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009308 | amine metabolic process | 4 | 1 |
GO:0009309 | amine biosynthetic process | 5 | 1 |
GO:0030148 | sphingolipid biosynthetic process | 5 | 1 |
GO:0034308 | primary alcohol metabolic process | 4 | 1 |
GO:0034309 | primary alcohol biosynthetic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0042401 | biogenic amine biosynthetic process | 6 | 1 |
GO:0042439 | ethanolamine-containing compound metabolic process | 4 | 1 |
GO:0043603 | amide metabolic process | 3 | 1 |
GO:0043604 | amide biosynthetic process | 4 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0044283 | small molecule biosynthetic process | 3 | 1 |
GO:0046165 | alcohol biosynthetic process | 4 | 1 |
GO:0046335 | ethanolamine biosynthetic process | 6 | 1 |
GO:0046467 | membrane lipid biosynthetic process | 4 | 1 |
GO:0046513 | ceramide biosynthetic process | 5 | 1 |
GO:1901160 | primary amino compound metabolic process | 4 | 1 |
GO:1901162 | primary amino compound biosynthetic process | 5 | 1 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
GO:1901615 | organic hydroxy compound metabolic process | 3 | 1 |
GO:1901617 | organic hydroxy compound biosynthetic process | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 16 |
GO:0016301 | kinase activity | 4 | 16 |
GO:0016740 | transferase activity | 2 | 16 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 16 |
GO:0016780 | phosphotransferase activity, for other substituted phosphate groups | 4 | 16 |
GO:0033188 | sphingomyelin synthase activity | 5 | 5 |
GO:0047493 | ceramide cholinephosphotransferase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 327 | 331 | PF00656 | 0.722 |
CLV_NRD_NRD_1 | 142 | 144 | PF00675 | 0.390 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.383 |
CLV_PCSK_SKI1_1 | 103 | 107 | PF00082 | 0.331 |
CLV_PCSK_SKI1_1 | 132 | 136 | PF00082 | 0.299 |
CLV_PCSK_SKI1_1 | 148 | 152 | PF00082 | 0.154 |
CLV_PCSK_SKI1_1 | 157 | 161 | PF00082 | 0.292 |
DOC_CDC14_PxL_1 | 35 | 43 | PF14671 | 0.286 |
DOC_CKS1_1 | 321 | 326 | PF01111 | 0.732 |
DOC_MAPK_MEF2A_6 | 244 | 253 | PF00069 | 0.334 |
DOC_MAPK_MEF2A_6 | 36 | 45 | PF00069 | 0.281 |
DOC_MAPK_MEF2A_6 | 66 | 73 | PF00069 | 0.288 |
DOC_PP1_RVXF_1 | 130 | 136 | PF00149 | 0.590 |
DOC_PP4_FxxP_1 | 237 | 240 | PF00568 | 0.524 |
DOC_USP7_MATH_1 | 260 | 264 | PF00917 | 0.281 |
DOC_WW_Pin1_4 | 232 | 237 | PF00397 | 0.424 |
DOC_WW_Pin1_4 | 320 | 325 | PF00397 | 0.733 |
DOC_WW_Pin1_4 | 342 | 347 | PF00397 | 0.658 |
DOC_WW_Pin1_4 | 364 | 369 | PF00397 | 0.716 |
LIG_14-3-3_CanoR_1 | 157 | 163 | PF00244 | 0.288 |
LIG_14-3-3_CanoR_1 | 244 | 250 | PF00244 | 0.299 |
LIG_14-3-3_CanoR_1 | 262 | 271 | PF00244 | 0.158 |
LIG_BRCT_BRCA1_1 | 115 | 119 | PF00533 | 0.596 |
LIG_BRCT_BRCA1_1 | 224 | 228 | PF00533 | 0.339 |
LIG_eIF4E_1 | 265 | 271 | PF01652 | 0.233 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.617 |
LIG_FHA_1 | 219 | 225 | PF00498 | 0.291 |
LIG_FHA_1 | 264 | 270 | PF00498 | 0.226 |
LIG_FHA_1 | 277 | 283 | PF00498 | 0.272 |
LIG_FHA_1 | 29 | 35 | PF00498 | 0.422 |
LIG_FHA_1 | 343 | 349 | PF00498 | 0.730 |
LIG_FHA_1 | 84 | 90 | PF00498 | 0.356 |
LIG_FHA_1 | 95 | 101 | PF00498 | 0.390 |
LIG_FHA_2 | 306 | 312 | PF00498 | 0.621 |
LIG_FHA_2 | 321 | 327 | PF00498 | 0.679 |
LIG_FHA_2 | 4 | 10 | PF00498 | 0.664 |
LIG_FHA_2 | 78 | 84 | PF00498 | 0.389 |
LIG_IRF3_LxIS_1 | 249 | 254 | PF10401 | 0.320 |
LIG_LIR_Apic_2 | 235 | 240 | PF02991 | 0.535 |
LIG_LIR_Gen_1 | 116 | 124 | PF02991 | 0.528 |
LIG_LIR_Gen_1 | 160 | 170 | PF02991 | 0.371 |
LIG_LIR_Gen_1 | 254 | 260 | PF02991 | 0.281 |
LIG_LIR_Nem_3 | 116 | 120 | PF02991 | 0.536 |
LIG_LIR_Nem_3 | 160 | 165 | PF02991 | 0.395 |
LIG_LIR_Nem_3 | 233 | 237 | PF02991 | 0.503 |
LIG_LIR_Nem_3 | 254 | 259 | PF02991 | 0.311 |
LIG_LIR_Nem_3 | 279 | 283 | PF02991 | 0.276 |
LIG_LIR_Nem_3 | 44 | 50 | PF02991 | 0.343 |
LIG_MYND_1 | 236 | 240 | PF01753 | 0.535 |
LIG_PCNA_yPIPBox_3 | 125 | 138 | PF02747 | 0.508 |
LIG_Pex14_2 | 228 | 232 | PF04695 | 0.395 |
LIG_Pex14_2 | 237 | 241 | PF04695 | 0.514 |
LIG_SH2_CRK | 162 | 166 | PF00017 | 0.292 |
LIG_SH2_CRK | 24 | 28 | PF00017 | 0.572 |
LIG_SH2_CRK | 256 | 260 | PF00017 | 0.292 |
LIG_SH2_PTP2 | 274 | 277 | PF00017 | 0.409 |
LIG_SH2_STAP1 | 162 | 166 | PF00017 | 0.292 |
LIG_SH2_STAP1 | 265 | 269 | PF00017 | 0.226 |
LIG_SH2_STAT5 | 256 | 259 | PF00017 | 0.286 |
LIG_SH2_STAT5 | 265 | 268 | PF00017 | 0.228 |
LIG_SH2_STAT5 | 274 | 277 | PF00017 | 0.305 |
LIG_SH3_1 | 343 | 349 | PF00018 | 0.552 |
LIG_SH3_3 | 246 | 252 | PF00018 | 0.304 |
LIG_SH3_3 | 318 | 324 | PF00018 | 0.736 |
LIG_SH3_3 | 343 | 349 | PF00018 | 0.675 |
LIG_SUMO_SIM_anti_2 | 315 | 323 | PF11976 | 0.720 |
LIG_SUMO_SIM_par_1 | 198 | 204 | PF11976 | 0.287 |
LIG_SUMO_SIM_par_1 | 315 | 323 | PF11976 | 0.723 |
LIG_TRAF2_1 | 308 | 311 | PF00917 | 0.545 |
LIG_TRAF2_1 | 314 | 317 | PF00917 | 0.580 |
LIG_TYR_ITIM | 253 | 258 | PF00017 | 0.339 |
LIG_TYR_ITSM | 158 | 165 | PF00017 | 0.395 |
LIG_WRC_WIRS_1 | 114 | 119 | PF05994 | 0.608 |
LIG_WRC_WIRS_1 | 126 | 131 | PF05994 | 0.602 |
MOD_CK1_1 | 152 | 158 | PF00069 | 0.511 |
MOD_CK1_1 | 218 | 224 | PF00069 | 0.272 |
MOD_CK1_1 | 263 | 269 | PF00069 | 0.270 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.665 |
MOD_CK2_1 | 305 | 311 | PF00069 | 0.490 |
MOD_CK2_1 | 320 | 326 | PF00069 | 0.677 |
MOD_CK2_1 | 77 | 83 | PF00069 | 0.281 |
MOD_CMANNOS | 300 | 303 | PF00535 | 0.417 |
MOD_Cter_Amidation | 140 | 143 | PF01082 | 0.396 |
MOD_GlcNHglycan | 139 | 142 | PF01048 | 0.380 |
MOD_GlcNHglycan | 206 | 209 | PF01048 | 0.569 |
MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.272 |
MOD_GlcNHglycan | 330 | 334 | PF01048 | 0.546 |
MOD_GlcNHglycan | 356 | 359 | PF01048 | 0.527 |
MOD_GlcNHglycan | 83 | 86 | PF01048 | 0.496 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.319 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.258 |
MOD_GSK3_1 | 322 | 329 | PF00069 | 0.741 |
MOD_GSK3_1 | 338 | 345 | PF00069 | 0.675 |
MOD_GSK3_1 | 349 | 356 | PF00069 | 0.751 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.207 |
MOD_N-GLC_1 | 93 | 98 | PF02516 | 0.389 |
MOD_N-GLC_2 | 183 | 185 | PF02516 | 0.560 |
MOD_NEK2_1 | 158 | 163 | PF00069 | 0.273 |
MOD_NEK2_1 | 174 | 179 | PF00069 | 0.281 |
MOD_NEK2_1 | 215 | 220 | PF00069 | 0.273 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.339 |
MOD_NEK2_1 | 276 | 281 | PF00069 | 0.377 |
MOD_NEK2_1 | 41 | 46 | PF00069 | 0.340 |
MOD_NEK2_1 | 81 | 86 | PF00069 | 0.356 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.409 |
MOD_PIKK_1 | 29 | 35 | PF00454 | 0.459 |
MOD_PK_1 | 338 | 344 | PF00069 | 0.557 |
MOD_PKA_2 | 377 | 383 | PF00069 | 0.636 |
MOD_Plk_1 | 329 | 335 | PF00069 | 0.561 |
MOD_Plk_1 | 338 | 344 | PF00069 | 0.549 |
MOD_Plk_1 | 93 | 99 | PF00069 | 0.424 |
MOD_Plk_4 | 125 | 131 | PF00069 | 0.517 |
MOD_Plk_4 | 198 | 204 | PF00069 | 0.293 |
MOD_Plk_4 | 218 | 224 | PF00069 | 0.292 |
MOD_Plk_4 | 245 | 251 | PF00069 | 0.254 |
MOD_Plk_4 | 41 | 47 | PF00069 | 0.297 |
MOD_Plk_4 | 77 | 83 | PF00069 | 0.360 |
MOD_Plk_4 | 94 | 100 | PF00069 | 0.254 |
MOD_ProDKin_1 | 232 | 238 | PF00069 | 0.424 |
MOD_ProDKin_1 | 320 | 326 | PF00069 | 0.734 |
MOD_ProDKin_1 | 342 | 348 | PF00069 | 0.658 |
MOD_ProDKin_1 | 364 | 370 | PF00069 | 0.718 |
TRG_DiLeu_BaEn_3 | 315 | 321 | PF01217 | 0.535 |
TRG_ENDOCYTIC_2 | 162 | 165 | PF00928 | 0.272 |
TRG_ENDOCYTIC_2 | 234 | 237 | PF00928 | 0.433 |
TRG_ENDOCYTIC_2 | 255 | 258 | PF00928 | 0.281 |
TRG_ENDOCYTIC_2 | 274 | 277 | PF00928 | 0.198 |
TRG_ENDOCYTIC_2 | 280 | 283 | PF00928 | 0.281 |
TRG_ER_diArg_1 | 142 | 144 | PF00400 | 0.588 |
TRG_Pf-PMV_PEXEL_1 | 66 | 70 | PF00026 | 0.542 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HRL7 | Leptomonas seymouri | 72% | 100% |
A0A0S4J1W3 | Bodo saltans | 46% | 100% |
A0A1X0P4U9 | Trypanosomatidae | 50% | 100% |
A0A3S7XA07 | Leishmania donovani | 85% | 99% |
A0A422NCN9 | Trypanosoma rangeli | 43% | 100% |
A4HNG1 | Leishmania braziliensis | 67% | 100% |
A4IC70 | Leishmania infantum | 86% | 99% |
B3A0L9 | Trypanosoma brucei brucei | 42% | 100% |
B3A0M0 | Trypanosoma brucei brucei | 43% | 100% |
B3A0M1 | Trypanosoma brucei brucei | 43% | 100% |
B3A0M2 | Trypanosoma brucei brucei | 42% | 100% |
C9ZYF5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
C9ZYF7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
C9ZYF8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
C9ZYF9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
C9ZYG0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
C9ZYG2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
E9AFX2 | Leishmania major | 87% | 100% |
Q20696 | Caenorhabditis elegans | 21% | 79% |
Q38E53 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 43% | 100% |
Q38E54 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 44% | 100% |
Q38E55 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 44% | 100% |
Q38E56 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 43% | 100% |
Q4E4I4 | Trypanosoma cruzi (strain CL Brener) | 52% | 100% |
Q4JM44 | Rattus norvegicus | 24% | 100% |
Q4R763 | Macaca fascicularis | 23% | 100% |
Q7T3T4 | Gallus gallus | 24% | 92% |
Q8NHU3 | Homo sapiens | 23% | 100% |
Q96LT4 | Homo sapiens | 24% | 92% |
Q9D4B1 | Mus musculus | 23% | 100% |
Q9DA37 | Mus musculus | 25% | 80% |